Organon & Co | OGN - Ebit

Stock Price
6.27
Daily Change
-0.08 -1.26%
Monthly
-13.87%
Yearly
-59.86%
Q1 Forecast
6.16

Organon & Co reported $388M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Deva Holding AS TRY 820.88M 192.13M Sep/2023
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -36K 12.96M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Novartis USD 4.48B 343M Sep/2025
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Organon & Co USD 388M 28M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Pharma Mar EUR 43.61M 47.57M Dec/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025